Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

ARROWHEAD PHARMACEUTICALS, INC. (ARWR) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

ARROWHEAD PHARMACEUTICALS, INC. (ARWR), most recent 12 months reported: revenue $669.5M, net loss $319.95M, free cash flow -$75.11M. Latest balance sheet on file: liquid cash $1.55B. From SEC filings. Others in Pharmaceutical Preparations: Amphastar Pharmaceuticals, Inc. · ULTRAGENYX PHARMACEUTICAL INC. · BridgeBio Pharma, Inc. · NURIX THERAPEUTICS, INC. · Mirum Pharmaceuticals, Inc. · TRAVERE THERAPEUTICS, INC. · OPKO Health, Inc. · HutchMED (China) LIMITED

Stock screener

Watchlist